Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Welch Foundation Gives $1.6 Million for Drug Discovery Research

Published: Monday, September 17, 2007
Last Updated: Monday, September 17, 2007
Bookmark and Share
UTMB scientist will lead computational chemistry program at John S. Dunn Gulf Coast Consortium for Chemical Genomics.

With a $1.6 million grant from the Welch Foundation, a coalition of six Gulf Coast institutions is launching a new initiative to develop computational and chemical techniques intended to speed the development of new drugs and molecular tools for biomedical science.

The Welch Foundation funding will enable the John S. Dunn Gulf Coast Consortium for Chemical Genomics (GCC CG) to establish a computational chemistry research program. The program is designed to fund multiple projects that bring together scientists involved with biomedical research and drug discovery: computational chemists, who work to produce computer models of real chemical systems that can be used to predict molecular properties; synthetic chemists, who specialize in building molecules designed for specific purposes; and biologists investigating systems can be applied to molecular intervention. Such studies are often the first step in the development of new drugs.

“We’re very grateful to the Welch Foundation for this gift, which continues its traditional mission of supporting the science of chemistry in Texas and also makes it possible for us to do medicinal chemistry that can have a real benefit for human health,” said University of Texas Medical Branch at Galveston (UTMB) professor Scott R. Gilbertson, the project’s principal investigator.

Gilbertson, who also holds one of UTMB’s two Robert A. Welch Distinguished Chairs in Chemistry, said the studies funded by the program will focus on small molecules’ effects on protein-protein interactions. Interactions between protein molecules are critical to many cellular processes. Developing molecules to control such interactions is becoming a central area in understanding cellular function as well as the discovery of important therapeutics.

“We think that collaborations between computational groups and synthetic groups in this area will promote better computing methods to predict molecular structure and function as well as better synthetic methods to check the computational predictions,” Gilbertson continued. “At the same time, we’ll be working on the first steps of discovering new drugs and scientifically useful small molecules.”

The program will complement the overall efforts of the GCC CG, according to Dr. Peter Davies, executive vice president for research at The University of Texas Health Science Center at Houston and co-director of the consortium, which is part of the Gulf Coast Consortia (GCC), a collaborative alliance for interdisciplinary bioscience research and training including UTMB, UT-Houston, Baylor College of Medicine, Rice University, the University of Texas M.D. Anderson Cancer Center and the University of Houston.

“The GCC CG was created to tackle the problem of finding molecules that can be used either as tools for research or potentially as new drugs, in a collaborative academic setting,” Davies said. “This generous gift from the Welch Foundation will ultimately help us harness the power of computational chemistry to much more efficiently select the compounds that go into our screening centers.”

“With this gift, the Welch Foundation not only opens new opportunities for both collaboration and discovery based in chemistry, but also continues its rich history of support for chemistry in Texas,” said Kathleen S. Matthews, dean of natural sciences at Rice University and chair of the oversight committee of the Gulf Coast Consortia. “The GCC community deeply appreciates the generous support of the Welch Foundation in this new and exciting endeavor in chemical genomics.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Can Cell Cycle Protein Prevent or Kill Breast Cancer Tumors?
An MD Anderson study has shown the potential of a simple molecule involved in cancer metabolism as a powerful therapeutic.
Monday, July 20, 2015
Partly Human Yeast Show A Common Ancestor’s Lasting Legacy
Edward Marcotte and his colleagues at the University of Texas at Austin created hundreds of strains of humanized yeast by inserting into each a single human gene and turning off the corresponding yeast gene.
Tuesday, May 26, 2015
Researchers Reveal Genomic Diversity Of Individual Lung Tumors
Findings suggest sequencing a single region of a localized tumor will identify driver mutations.
Friday, October 10, 2014
Metabolic Protein Launches Sugar Feast that Nurtures Brain Tumors
PKM2 slips into nucleus to promote cancer; potential biomarker and drug approach discovered.
Wednesday, November 28, 2012
Ancient Enzymes Function like Nanopistons to Unwind RNA
Molecular biologists have solved one of the mysteries of how double-stranded RNA is remodeled inside cells in both their normal and disease states.
Wednesday, September 05, 2012
New Genomic Technique Uncovers Coral Transcriptome
Researchers have uncovered the larval transcriptome of a reef-building coral by utilizing a new technique for cDNA preparation.
Tuesday, May 12, 2009
Genetic Variation Raises HIV Risk in People of African Descent
A genetic variation that may have protected people of African descent against a pandemic of malaria long ago now appears to increase their susceptibility to HIV infection.
Wednesday, July 23, 2008
When she's Turned on, Some of Her Genes Turn Off
When a female is attracted to a male, entire suites of genes in her brain turn on and off, show biologists from The University of Texas at Austin studying swordtail fish.
Thursday, December 20, 2007
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Study Finds Non-Genetic Cancer Mechanism
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
The Mystery of the Instant Noodle Chromosomes
Researchers from the Lomonosov Moscow State University evaluated the benefits of placing the DNA on the principle of spaghetti.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!